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Abstract
Introduction: Allergic rhinitis (AR) is an IgE-mediated non-infectious disease of the nasal muco-
sa following contact with allergens. 
Objective: To investigate the peripheral Th17 cells and CD4 + CD25 + Foxp3 +  regulatory T 
(Treg) cells and the expression of cytokines in the serum of AR patients.
Methods: The peripheral blood of 14 patients with AR (AR group) and six healthy subjects (con-
trol group) was collected from March to May of 2012. Flow cytometry was performed to detect 
the Th17 cells and Treg cells, and enzyme-linked immunosorbent assay (ELISA) to measure the 
serum levels of IL-17 and TGF-&#946;1. 
Results: The proportion of Th17 cells in the AR group was markedly higher than that in the con-
trol group (p < 0.01). The proportion of Treg cells in the AR group was also dramatically reduced 
when compared with the control group (p < 0.01). In the AR group, serum IL-17 levels were 
markedly higher than those in the control group (p < 0.01). In the AR group, serum TGF-&#946;1 
levels were significantly lower than those in the control group (p < 0.01). 
Conclusion: The imbalance of peripheral Th17/Treg cells plays an important role in the patho-
genesis of AR.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier 
Editora Ltda. All rights reserved.
 
Desequilíbrio imunológico periférico mediado por células Th17/Treg em pacientes com rinite 
alérgica
Resumo
Introdução: A rinite alérgica (RA) é uma doença não infecciosa da mucosa nasal mediada por IgE 
após o contato com alérgenos.
Objetivo: Investigar as células Th17 periféricas e CD4 + CD25 + Foxp3 + células T reguladoras 
(Treg) e a expressão sérica de citocinas em pacientes com RA. 
Métodos: De março a maio de 2012, foi coletado o sangue periférico de 14 pacientes com RA 
(grupo RA) e seis indivíduos saudáveis (grupo controle). A detecção das células Th17 e células 
Treg foi realizada através da citometria de fluxo e os níveis séricos de IL -17 e TGF- β1. Foram 
medidos por ELISA. 
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Introduction
Allergic rhinitis (AR) is an IgE-mediated non-infectious dise-
ase of the nasal mucosa following contact with allergens.1 
Previous studies have demonstrated that imbalance of Th1/
Th2 cell-mediated immunity has an important role in the 
pathogenesis of AR, which is characterized by Th2 cell-me-
diated inflammation.2 In recent years, there is evidence 
showing that regulatory T (Treg) cells are another subset of 
T lymphocytes involved in allergic diseases and can regulate 
the pathological and physiological immune response, whi-
ch may promote self-immune tolerance and maintenance 
of immune balance.3 CD4+CD25+ Treg cells are the major 
type of Treg cells; they can secret some cytokines, including 
TGF-β1 and IL-10. Forkhead box p3 (Foxp3) gene is a critical 
regulatory gene in the development and functional mainte-
nance of CD4+CD25+ Treg cells.4 
Th17 cells are a subset of T lymphocytes that play cru-
cial roles in pro-inflammatory inflammation and autoimmu-
ne diseases. RORγt is a key nuclear transcription factor of 
Th17 cells, and IL-17 is an important effector cytokine se-
creted by these cells. IL-17 can exert a pro-inflammatory 
effect, promote the production of chemokines (such as IL-8 
and monocyte chemoattractant protein-1, among others) in 
the local tissues, facilitate the proliferation of monocytes 
and neutrophils, and stimulate the generation of IL-6 and 
prostaglandin E2, resulting in local inflammation.5,6 Some 
researchers, using real-time polymerase chain reaction (RT-
-PCR) and enzyme-linked immunosorbent assay (ELISA) for 
the detection of associated transcription factors and cy-
tokines of Th17 and Treg cells in the peripheral blood of AR 
patients, observed that the expression of RORγt and IL-17 
increased and the expression of Foxp3 (transcription factor 
of Treg cells) and TGF-β1 (associated cytokine) decreased.7 
In the present study, flow cytometry (FCM) and ELISA were 
employed to detect the Th17/Treg cells and serum levels of 
IL-17 and TGF-β1, respectively, aiming to explore the role of 
Th17/Treg cells in the pathogenesis of AR. 
Materials and methods 
Subjects
From March to May of 2012, a total 14 patients with AR were 
admitted into this department: five males and nine fema-
les, with a mean age of 29.76 years. The diagnosis of AR 
was made according to its diagnostic criteria.1 Skin- prick 
test results were positive for dust mite; the severity of AR 
was moderate or severe in all 14 patients. These patients 
had not been treated with glucocorticoids in the past month 
and had not received anti-histamine therapy and allergen-s-
pecific immunotherapy. Patients with sinusitis, asthma, and 
intolerance to acetylsalicylic acid were excluded. Additio-
nally, six healthy volunteers without symptoms of AR were 
recruited as controls: two males and four females, with a 
mean age of 30.83 years. All subjects signed an informed 
consent prior to their enrollment in the study. 
Main reagents and instrument
Flow cytometer (FACSCalibur; BD - USA) was used for de-
tection and Cellquest software (BD - USA) was employed for 
the acquisition of data and subsequent analysis. Microplate 
reader (ELX-800; Bio-Tek - USA), PMA, ionomycin calcium, 
BFA (MultiSciences), Human Regulatory T Cell Staining Kit 
(eBioscience - USA), APC-conjugated human CD8 mAb (BD 
- USA), PerCP-Cy5.5 conjugated human CD3 mAb, PE-con-
jugated human IL-17 mAb and corresponding istype control 
(eBioscience - USA), fixation solution and membrane rup-
ture solution (Invitrogen - USA), anti-human IL-17 ELISA kit 
(eBioscience - USA), and TGF-β1 ELISA kit (RayBio - USA) 
were used in the present study. 
Sample collection
In the morning, venous blood samples (4 mL) were collected 
from the ulnar vein and anti-coagulated with heparin. Then, 
2 mL of blood were subjected to centrifugation at 3,000 
rpm for 15; the serum was collected and stored at -20°C 
for the detection of IL-17 and TGF-β1. In addition, the re-
maining 2 mL of blood were used for flow cytometry for the 
detection of Th17 cells and Treg cells. 
Detection of Th17 cells by FCM
In brief, 250 μL of peripheral blood were mixed with 50 
μg/L PMA, 2.0 μmol/L monensin, and 750 μmoL/L ionomycin 
calcium, followed by incubation at 37°C in an environment 
with 50 mL/L CO2 for 4 h. The cell suspension was trans-
ferred into a 1.5 ml-PE tube followed by centrifugation at 
2,500 rpm for 6 min. The supernatant was removed, and the 
cells were washed with PBS twice for FCM. The cells were 
treated with 10 μL of PECy5-CD3Ab and 10 μL of FITC-CD8Ab 
at room temperature, in a dark environment, for 30 min. 
Resultados: A percentagem de células Th17 no grupo RA foi bem maior do que no grupo controle 
(p < 0,01). A proporção de células Treg no grupo RA também foi drasticamente menor quando 
comparada ao grupo controle (p < 0,01). No grupo RA, o nível sérico de IL-17 foi significativa-
mente maior do que no grupo controle (p < 0,01). 
Conclusão: O desequilíbrio de células Th17/Treg periféricas desempenha um papel importante 
na patogênese da RA.
© 2014 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Publicado por Elsevier 
Editora Ltda. Todos os direitos reservados.
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After washing in PBS twice, the cells were fixed in 300 μL of 
fixation solution in a dark environment at 4°C for 15 min. Af-
ter centrifugation, the supernatant was removed. Following 
the addition of membrane rupture solution, centrifugation 
was performed at 3,000 rpm and the supernatant was remo-
ved. After washing in PBS twice, cells were transferred into 
two tubes and treated with 20 μL of PE-IL-17Ab and 10 μL of 
isotype control PE-IgG1, respectively, in a dark environment 
at room temperature for 30 min. After washing in PBS twice, 
cells were re-suspended in 0.3 mL of PBS and subjected to 
FCM. CellQuest software was employed for data analysis.
Detection of Treg cells by FCM
Cells were transferred into sample tube and control tube. 
Cells in the sample tube were treated with CD4/CD25/
Foxp3, and those in the control group were treated with 
Foxp3 isotype control (CD4/CD25/mouse IgG). Then, 100 
μL of anti-coagulated blood was added followed by incu-
bation in a dark environment at room temperature for 20 
min. Following the addition of 1 mL of hemolytic agent, 
incubation was performed at room temperature in a dark 
environment for 10 min followed by centrifugation at 1,000 
rpm for 5 min. The supernatant was removed and cells were 
re-suspended in 1 mL of PBS followed by centrifugation at 
1,000 rpm for 5 min. The supernatant was then removed, 
and 0.5 mL of Foxp3 fixation solution were added, followed 
by incubation in a dark environment at room temperature 
for 20 min. Cells were re-suspended in 1 mL of PBS, and 
centrifuged at 1,000 rpm for 5 min. The supernatant was 
removed, and 0.5 mL of Foxp3 membrane rupture solution 
was added to each tube, followed by centrifugation at 1,000 
rpm for 5 min. These cells were re-suspended in 0.5 mL of 
Foxp3 membrane rupture solution, followed by incubation 
in a dark environment at room temperature for 15 min. Af-
ter centrifugation at 1,000 rpm for 5 min, the supernatant 
was removed. Then, 10 μL of PE Foxp3Ab were added to the 
sample tube and 10 μL of isotype control were added to the 
control tube, followed by incubation at room temperature 
in a dark environment for 30 min. Cells were re-suspended 
in 1 mL of PBS and centrifuged at 1,000 rpm for 5 min. The 
supernatant was removed and the cells were re-suspended 
in 0.4 mL of PBS. FCM was performed and CellQuest softwa-
re was employed for data analysis.
Detection of serum IL-17 and TGF-β1 by ELISA
The detection of serum contents of IL-17 and TGF-β1 was 
performed according to the manufacturer’s instructions. 
The lower limit of detection was 0.5 pg/mL for IL-17 and 9 
pg/mL for TGF-β1. 
Statistical analysis
Statistical analysis was performed with SPSS version 16.0. 
Data with normal distribution were expressed as mean ± 
standard deviation. Student’s t-test for independent varia-
bles was performed for comparisons between two groups. 
A value of p < 0.05 was considered statistically significant. 
Results 
Proportion of Th17 cells in AR group and control 
group
FCM demonstrated that the proportion of Th17 cells in the 
AR group was markedly higher than that of the control group 
(p < 0.01; Table 1). 
Proportion of Treg cells in AR group and control 
group
In the AR group, the proportion of Treg cells was markedly 
reduced when compared to the control group (p < 0.01; Ta-
ble 1).
Serum contents of IL-17 and TGFβ1 in AR group and con-
trol group
ELISA was performed to detect the serum contents of IL-17 
and TGF-β1 in the AR group and control group. Data are 
shown in Table 2. Results demonstrated that the IL-17 le-
vel in the AR group was markedly higher than that of the 
control group (p < 0.01). In the AR group, the TGF-β1 level 
was dramatically reduced when compared with the control 
group (p < 0.01). 
Table 1 Proportion of Th17 cells and regulatory T (Treg) 
cells in the allergic rhinitis (AR) group and control group 
(mean ± standard deviation).
Group Th17 (%) Treg (%)
AR (n = 14) 1.69 ± 0.64a 1.82 ± 0.76b
Control (n = 6) 0.59 ± 0.19 5.19 ± 2.10
a p < 0.01 vs. control group.
b p < 0.01 vs. control group. 
Table 2 Serum levels of IL-17 and TGF-β1 in the allergic 
rhinitis (AR) group and control group (mean ± standard 
deviation; pg/mL)
IL-17 TGF-β1 
AR (n = 14) 668.68 ± 62.59a 0.37 ± 0.05b
Control (n = 6) 668.68 ± 28.00 0.50 ± 0.07
a p < 0.01 vs. control group.
b p < 0.01 vs. control group. 
Discussion 
Previous studies have demonstrated that the serum level of 
IL-17 in AR patients was significantly increased when compa-
red with controls,8 and that the proportion of IL-17 positive 
cells in the nasal mucosa in AR patients was also markedly 
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higher than that in healthy subjects.9 Ciprandi et al.10,11 
observed that the serum IL-17 level was positively related 
to the severity of symptoms of AR and positively associated 
with the number of peripheral eosinophils. The peripheral 
monocytes from AR patients who were treated with pollen 
allergen and FCM showed the proportion of Th17 cells was 
markedly higher than that in the control group. In the pre-
sent study, the results indicated that the proportion of pe-
ripheral Th17 cells in AR patients was significantly higher 
than that of the controls, accompanied by the increase in 
serum level of IL-17. These findings suggest that Th17 cells 
can secret a large amount of IL-17, which is involved in the 
pathogenesis of AR. 
Additionally, the proportion of CD4 + CD25 + Treg cells 
in peripheral blood of AR patients was significantly lower 
than that of the controls, accompanied by the reduction 
of serum TGF-β1 level. This suggests that the reduction of 
peripheral Treg cell count leads to a compromised function 
of these cells. In healthy subjects, the proportion of CD4 + 
CD25 + Treg cells was approximately 5% to 10% in the peri-
pheral blood. The CD4 +  CD25 + Treg cells can exert inhi-
bitory effect on the immune response via the intercellular 
interaction or secretion of inhibitory cytokines (such as IL-
10 and TGF-β).4 The present results demonstrated that the 
proportion of peripheral CD4 + CD25 + Treg cells and the 
serum level of TGF-β1 were reduced. Xu et al.12 confirmed 
that the Foxp3 + positive lymphocytes and Foxp3 mRNA ex-
pression in the nasal mucosa and peripheral monocytes of 
AR patients were markedly reduced when compared with 
healthy controls, and that Foxp3 and CD4 + CD25 + Treg cells 
in allergy patients were markedly reduced.13 This suggests 
that the compromised inhibitory effect of Treg cells leads to 
the occurrence of allergic diseases. 
Th17 cells and Treg cells are derived from naïve T cells. 
Th17 cells mediate the inflammatory reaction, whereas Treg 
cells mediate immune tolerance. There is antagonism in the 
function and differentiation of Th17 cells and Treg cells. 
Thus, the balance of Treg cells and Th17 cells is crucial for 
the maintenance of the immune status. In the present study, 
the results demonstrated that the proportion of Th17 cells 
in the peripheral blood of AR patients was markedly incre-
ased and that of Treg cells was dramatically reduced. This 
suggests that Th17/Treg imbalance plays an important role 
in the pathogenesis of AR. Further research in the Th17/
Treg balance may provide a novel strategy for the treatment 
of AR.
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